Home » Topics » BioWorld Science

BioWorld Science
RSS

Novel malaria vaccine candidate developed using recombinant SAMSP1 mosquito saliva protein

Sep. 21, 2021

New HIV replication inhibitors discovered at Gilead

Sep. 21, 2021

Remix Therapeutics patents RNA splicing modulators

Sep. 21, 2021

New PBP3 ligands identified at Bicycletx

Sep. 21, 2021

UCB describes new IL-17 modulators

Sep. 21, 2021

PF-06873600 disrupts cell-cycle progression and shows antitumor activity in vivo

Sep. 21, 2021

Exosome-mediated transcellular delivery of SIRT2 modulates ATP homeostasis within axons

Sep. 21, 2021

BET protein inhibition can reverse CAR T-cell exhaustion

Sep. 20, 2021

ETX-0462 is a potent antibiotic against Pseudomonas aeruginosa

Sep. 20, 2021

SpectrumX reports in vitro neutralizing efficacy of SPC-069 against SARS-CoV-2 variants

Sep. 20, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...